First Mercantile Trust’s Adaptive Biotechnologies ADPT Stock Holding History

First Mercantile Trust’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$257K	Sell	7,575 -2,700	-26%	-$97.7K	0.03%	322
2021 Q2	$420K	Sell	10,275 -275	-3%	-$10.7K	0.05%	216
2021 Q1	$425K	Hold	10,550	–	–	0.05%	215
2020 Q4	$624K	Buy	10,550 +3,300	+46%	+$170K	0.07%	153
2020 Q3	$349K	Buy	7,250 +3,250	+81%	+$137K	0.04%	240
2020 Q2	$194K	Hold	4,000	–	–	0.02%	415
2020 Q1	$111K	Buy	4,000 +1,600	+67%	+$44.6K	0.02%	526
2019 Q4	$72K	Buy	+2,400	New	+$68.9K	0.01%	746

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

First Mercantile Trust's ADPT Position: Q3 2021 in Review

First Mercantile Trust reduced its Adaptive Biotechnologies (ADPT) stake by 26% in Q3 2021, selling an estimated $97.7K and leaving 7,575 shares worth $257K. The position accounts for 0.03% of the portfolio, ranked #322.

First Mercantile Trust first reported a position in ADPT in Q4 2019 and has held it in 8 quarters since. The position peaked at $624K in Q4 2020. 219 funds tracked by Wall St. Rank hold ADPT as of Q3 2021.

First Mercantile Trust held 7,575 shares of Adaptive Biotechnologies worth $257K as of Q3 2021.
First Mercantile Trust sold 2,700 Adaptive Biotechnologies shares in Q3 2021, an estimated $97.7K.
Adaptive Biotechnologies made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #322 holding.
First Mercantile Trust first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 8 quarters since.
First Mercantile Trust's Adaptive Biotechnologies position peaked at $624K in Q4 2020.
219 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.